Literature DB >> 29570431

G protein-coupled receptor kinase-2-deficient mice are protected from dextran sodium sulfate-induced acute colitis.

Michael D Steury1, Ho Jun Kang1, Taehyung Lee1, Peter C Lucas2, Laura R McCabe1, Narayanan Parameswaran1.   

Abstract

G protein-coupled receptor kinase 2 (GRK2) is a serine/threonine kinase and plays a key role in different disease processes. Previously, we showed that GRK2 knockdown enhances wound healing in colonic epithelial cells. Therefore, we hypothesized that ablation of GRK2 would protect mice from dextran sodium sulfate (DSS)-induced acute colitis. To test this, we administered DSS to wild-type (GRK2+/+) and GRK2 heterozygous (GRK+/-) mice in their drinking water for 7 days. As predicted, GRK2+/- mice were protected from colitis as demonstrated by decreased weight loss (20% loss in GRK2+/+ vs. 11% loss in GRK2+/-). lower disease activity index (GRK2+/+ 9.1 vs GRK2+/- 4.1), and increased colon lengths (GRK2+/+ 4.7 cm vs GRK2+/- 5.3 cm). To examine the mechanisms by which GRK2+/- mice are protected from colitis, we investigated expression of inflammatory genes in the colon as well as immune cell profiles in colonic lamina propria, mesenteric lymph node, and in bone marrow. Our results did not reveal differences in immune cell profiles between the two genotypes. However, expression of inflammatory genes was significantly decreased in DSS-treated GRK2+/- mice compared with GRK2+/+. To understand the mechanisms, we generated myeloid-specific GRK2 knockout mice and subjected them to DSS-induced colitis. Similar to whole body GRK2 heterozygous knockout mice, myeloid-specific knockout of GRK2 was sufficient for the protection from DSS-induced colitis. Together our results indicate that deficiency of GRK2 protects mice from DSS-induced colitis and further suggests that the mechanism of this effect is likely via GRK2 regulation of inflammatory genes in the myeloid cells.

Entities:  

Keywords:  GRK2; IBD; colitis; cytokines; myeloid-specific

Mesh:

Substances:

Year:  2018        PMID: 29570431      PMCID: PMC6032290          DOI: 10.1152/physiolgenomics.00006.2018

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  44 in total

Review 1.  GRK2: multiple roles beyond G protein-coupled receptor desensitization.

Authors:  Tama Evron; Tanya L Daigle; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2012-01-23       Impact factor: 14.819

Review 2.  Epithelial cells as sensors for microbial infection.

Authors:  M F Kagnoff; L Eckmann
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Non-Hematopoietic β-Arrestin1 Confers Protection Against Experimental Colitis.

Authors:  Taehyung Lee; Eunhee Lee; David Arrollo; Peter C Lucas; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2015-11-20       Impact factor: 6.384

4.  G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Anne Vroon; Annemieke Kavelaars; Volker Limmroth; Maria Stella Lombardi; Marion U Goebel; Anne-Marie Van Dam; Marc G Caron; Manfred Schedlowski; Cobi J Heijnen
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

5.  Monocytes/Macrophages control resolution of transient inflammatory pain.

Authors:  Hanneke L D M Willemen; Niels Eijkelkamp; Anibal Garza Carbajal; Huijing Wang; Matthias Mack; Jitske Zijlstra; Cobi J Heijnen; Annemieke Kavelaars
Journal:  J Pain       Date:  2014-05       Impact factor: 5.820

6.  Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling.

Authors:  Scot J Matkovich; Abhinav Diwan; Justin L Klanke; Daniel J Hammer; Yehia Marreez; Amy M Odley; Eric W Brunskill; Walter J Koch; Robert J Schwartz; Gerald W Dorn
Journal:  Circ Res       Date:  2006-09-28       Impact factor: 17.367

7.  Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).

Authors:  Teresa K Tarrant; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Peng Liu; Richard T Premont; Robert J Lefkowitz; David M Lee; Dhavalkumar D Patel
Journal:  Clin Immunol       Date:  2008-07-26       Impact factor: 3.969

Review 8.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Authors:  Dmitry V Ostanin; Jianxiong Bao; Iurii Koboziev; Laura Gray; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; V Hugh Price; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

9.  Nonhematopoietic β-Arrestin-1 inhibits inflammation in a murine model of polymicrobial sepsis.

Authors:  Deepika Sharma; Nandakumar Packiriswamy; Ankit Malik; Peter C Lucas; Narayanan Parameswaran
Journal:  Am J Pathol       Date:  2014-06-17       Impact factor: 4.307

Review 10.  The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.

Authors:  Jonathan Hullmann; Christopher J Traynham; Ryan C Coleman; Walter J Koch
Journal:  Pharmacol Res       Date:  2016-05-12       Impact factor: 7.658

View more
  3 in total

Review 1.  RGS proteins, GRKs, and beta-arrestins modulate G protein-mediated signaling pathways in asthma.

Authors:  Nathalie Fuentes; Morgan McCullough; Reynold A Panettieri; Kirk M Druey
Journal:  Pharmacol Ther       Date:  2021-02-15       Impact factor: 13.400

2.  Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes.

Authors:  Fraser L Collins; Naiomy Deliz Rios-Arce; Jonathan D Schepper; A Daniel Jones; Laura Schaefer; Robert A Britton; Laura R McCabe; Narayanan Parameswaran
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

Review 3.  The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart.

Authors:  Joshua Abd Alla; Ursula Quitterer
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.